PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+4.46%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.62B
AUM Growth
-$230M
(-8.1%)
Cap. Flow
-$480M
Cap. Flow
% of AUM
-18.35%
Top 10 Holdings %
Top 10 Hldgs %
33.63%
Holding
107
New
21
Increased
20
Reduced
20
Closed
27
Top Buys
| 1 |
AET
Aetna Inc
AET
|
$98.3M |
| 2 |
Biogen
BIIB
|
$81.1M |
| 3 |
DISH
DISH Network Corp.
DISH
|
$62.8M |
| 4 |
Baxter International
BAX
|
$61.3M |
| 5 |
Meta Platforms (Facebook)
META
|
$53.2M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$107M |
| 2 |
Bristol-Myers Squibb
BMY
|
$97.9M |
| 3 |
Apple
AAPL
|
$91.2M |
| 4 |
Lam Research
LRCX
|
$90.7M |
| 5 |
AGN
Allergan plc
AGN
|
$84.2M |
Sector Composition
| 1 | Healthcare | 49.14% |
| 2 | Technology | 11.79% |
| 3 | Communication Services | 5.92% |
| 4 | Energy | 5.06% |
| 5 | Financials | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HDP
51
DELISTED
Hortonworks, Inc.
HDP
| $12.5M | 0.38% |
1,172,433
-183,537
| -14% | -$1.96M |
|
|
52
Apple
AAPL
$3.54T
| $12.5M | 0.38% |
522,640
-3,816,372
| -88% | -$91.2M |
|
53
LivaNova
LIVN
$3.09B
| $12.3M | 0.37% |
+244,851
| New | +$12.3M |
|
54
Vertex Pharmaceuticals
VRTX
$102B
| $11.7M | 0.35% |
+135,487
| New | +$11.7M |
|
|
MYOK
55
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $10.4M | 0.31% |
838,810
+74,178
| +10% | +$920K |
|
|
SPNC
56
DELISTED
Spectranetics Corp
SPNC
| $4.83M | 0.15% |
258,019
-35,561
| -12% | -$665K |
|
57
Kura Oncology
KURA
$732M
| $4.53M | 0.14% |
1,671,164
+129,212
| +8% | +$350K |
|
|
DMTX
58
DELISTED
Dimension Therapeutics, Inc
DMTX
| $4M | 0.12% |
666,070
-59,099
| -8% | -$355K |
|
59
Penumbra
PEN
$10.5B
| $2.27M | 0.07% |
38,186
-24,859
| -39% | -$1.48M |
|
|
ARA
60
DELISTED
American Renal Associates Holdings, Inc
ARA
| $1.52M | 0.05% |
+52,427
| New | +$1.52M |
|
61
Innoviva
INVA
$1.32B
| $1.41M | 0.04% |
133,897
-1,352,317
| -91% | -$14.2M |
|
|
62
Lam Research
LRCX
$124B
| – | – |
-10,986,460
| Closed | -$90.7M |
|
63
Acadia Healthcare
ACHC
$2.15B
| – | – |
-130,817
| Closed | -$7.21M |
|
64
American Tower
AMT
$91.9B
| – | – |
-123,422
| Closed | -$12.6M |
|
65
Blackrock
BLK
$170B
| – | – |
-189,158
| Closed | -$64.4M |
|
66
Charter Communications
CHTR
$35.7B
| – | – |
-142,999
| Closed | -$28.9M |
|
67
Salesforce
CRM
$245B
| – | – |
-351,492
| Closed | -$26M |
|
68
DaVita
DVA
$9.72B
| – | – |
-173,585
| Closed | -$12.7M |
|
69
DexCom
DXCM
$30.9B
| – | – |
-682,140
| Closed | -$11.6M |
|
70
iShares MSCI Emerging Markets ETF
EEM
$19B
| – | – |
0
| – | – |
|
71
Elevance Health
ELV
$72.4B
| – | – |
-518,909
| Closed | -$72.1M |
|
72
Gilead Sciences
GILD
$140B
| – | – |
-835,032
| Closed | -$76.7M |
|
73
Alphabet (Google) Class A
GOOGL
$2.79T
| – | – |
-2,042,300
| Closed | -$77.9M |
|
74
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.7B
| – | – |
0
| – | – |
|
75
iShares Biotechnology ETF
IBB
$5.68B
| – | – |
-241,539
| Closed | -$21M |
|